1st Quarter - Report
BALLARD PARTNERS for JUBILANT PHARMA HOLDINGS INC.
Firm
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade/USMCA renegotiations; Domestic investment
Foreign entity interest: Jubilant Pharma, Ltd., Jubilant Pharmova, and Jubilant Bhartia Group, foreign parent companies identified on the LD-1 report, have direct or indirect interests in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BALLARD | — |
| HUNTER MORGEN | Policy Advisor, Office of Policy Planning, U.S. State Dept. (2017); Deputy Director, Office of Trade & Manufacturing Policy, WH (2017-2018); Special Assistant to the President, Office of the Senior Advisor for Policy, WH (2018-2020) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.